REGENXBIO Inc.

RGNX ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2024

Total Assets: $466.0M

Liabilities Breakdown FY2024

Total Liabilities: $206.3M